MD Anderson Statement Regarding Third Dose of COVID-19 Vaccine for Immunocompromised Patients
August 25, 2021
August 25, 2021
HOUSTON, Texas, Aug. 25 (TNSRes) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
A multidisciplinary group of oncology and infectious disease experts at The University of Texas MD Anderson Cancer Center have reviewed all available data from the Food and Drug Administration and the Centers for Disease Control and Prevention regarding the administration of a third dose of COVID-19 vaccines for people with weakened immune systems. These ex . . .
A multidisciplinary group of oncology and infectious disease experts at The University of Texas MD Anderson Cancer Center have reviewed all available data from the Food and Drug Administration and the Centers for Disease Control and Prevention regarding the administration of a third dose of COVID-19 vaccines for people with weakened immune systems. These ex . . .